Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Practice Guidelines
    • Cancer Guidelines
    • Updated guideline for...

    Updated guideline for management of people at increased pancreatic cancer risk

    Written by Medha Baranwal Baranwal Published On 2019-11-27T19:00:18+05:30  |  Updated On 12 Oct 2022 12:04 PM IST
    Updated guideline for management of people at increased pancreatic cancer risk

    The International Cancer of the Pancreas Screening (CAPS) Consortium has released updated guidance for the management of individuals with increased risk of pancreatic cancer based on family history or germline mutation status (high-risk individuals). The recommendations are published in the BMJ journal Gut.


    The guideline recommends pancreatic surveillance for selected high-risk individuals to detect early pancreatic cancer and its high-grade precursors but should be performed in a research setting by multidisciplinary teams in centers with appropriate expertise.


    Other Key Recommendations include:

    • Offer surveillance to:

      • All patients with Peutz-Jeghers syndrome (carriers of LKB1/STK11 mutation)

      • All carriers of CDKN2A mutation

      • Carriers of BRCA2, BRCA1, PALB2, ATM, MLH1, MSH2 or MSH6 mutation, with ≥1 affected first-degree blood relative

      • Individuals with ≥1 first-degree relative with pancreatic cancer who also have a first-degree relative with pancreatic cancer (familial pancreatic cancer kindred)



    • Surveillance should be started in:

      • Familial pancreatic cancer kindred (without known mutation): age 50 or 55 years or 10 years younger than the youngest affected blood relative (YABR)

      • CDKN2A Peutz-Jegher syndrome: age 40 years

      • BRCA2, ATM, PALB2, BRCA1, MLH1/MSH2: age 45 or 50 years or 10 years younger than YABR



    • MRI/MRCP+EUS + fasting blood glucose and/or HbA1c at baseline should be measured.

    • During follow-up, routine fasting blood glucose and/or HbA1, and alternate MRI/MRCP and EUS.

    • Serum CA 19-9 should be performed if concerning features on imaging.

    • EUS-FNA should be performed only for:

      • Solid lesions ≥5 mm

      • Cystic lesions with worrisome features

      • Asymptomatic main pancreatic duct (MPD) strictures (with/without mass)



    • CT should be performed only for:

      • Solid lesions (any size)

      • Asymptomatic MPD strictures of unknown aetiology (without mass)



    • Follow-up should be performed for:

      • 12 months if no abnormalities or concerning abnormalities occur

      • 3-6 months if concerning abnormalities are not indicated for immediate surgery




    "Until more evidence supporting these recommendations is available, the benefits, risks and costs of surveillance of pancreatic surveillance need additional evaluation," concluded the authors.


    The guideline, "Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium," is published in the BMJ journal Gut.

    DOI: http://dx.doi.org/10.1136/gutjnl-2019-319352

    Journal Information: Gut
    BMJInternational Cancer of the Pancreas Screeningpancreatic cancer
    Source : BMJ journal Gut

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medha Baranwal Baranwal
    Medha Baranwal Baranwal
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok